fr   en

Tableaux synoptiques (en anglais)

Parcourir par date
Rechercher par mot clé
Date: 2006-02-08
Biotech partner: NPS Pharmaceuticals (USA)
Pharma Partner: AstraZeneca (UK)
Type of agreement: * R&D
* commercialization/ distribution
Compound: drugs targeting metabotropic glutamate receptors
Disease area: CNS diseases, gastro-intestinal pathologies
Development phase:  
Nature of the agreement: extension of an agreement signed in March 2001. This new 3-year agreement includes an option for an additional 2-year extension.
Financial terms of the agreement:  

Go back to previous page